arrow
C

Ching-Chuan Kuo

China Medical University Taiwan
H指数:40
被引数:4,336

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization
2024-11-260
OAAI
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death

使用RBC衍生的囊泡通过线粒体依赖性细胞死亡克服耐药性癌症的溶酶体靶向阿霉素递送

2023-11-012
OAAI
Discovery and development of a novel N-(3-bromophenyl)- {[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design

使用基于知识的药物设计发现和开发新型N-(3-溴苯基)- {[(苯基氨基甲酰基) 氨基] 甲基}-N-hydroxythiophene-2-carboximidamide吲哚胺2,3-双加氧酶抑制剂

2022-02-011
PRE
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors (vol 63, pg 1642, 2020)
2020-06-231
OAAI
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors
2020-01-2132
PREAI
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia
2019-11-135
PREAI